Methaniazide/thioacetazone

Methaniazide/thioacetazone is a combination medication used in the treatment of tuberculosis. It contains two active ingredients: methaniazide and thioacetazone.

Overview

Methaniazide/thioacetazone is a combination drug that is used to treat tuberculosis, a serious infectious disease that primarily affects the lungs. The medication contains two active ingredients: methaniazide, a sulfonamide antibiotic, and thioacetazone, a thioamide antibiotic.

Mechanism of Action

Both methaniazide and thioacetazone work by inhibiting the growth of the bacteria that cause tuberculosis. Methaniazide inhibits the synthesis of mycolic acids, an essential component of the bacterial cell wall. Thioacetazone, on the other hand, interferes with the bacteria's ability to synthesize nucleic acids, thereby preventing the bacteria from reproducing.

Side Effects

Like all medications, methaniazide/thioacetazone can cause side effects. Common side effects include nausea, vomiting, and diarrhea. More serious side effects can include hepatotoxicity, neurotoxicity, and hypersensitivity reactions.

Precautions

Before starting treatment with methaniazide/thioacetazone, patients should inform their healthcare provider about any other medications they are taking, as well as any allergies or other health conditions they have. This medication should be used with caution in patients with liver disease or kidney disease, and is not recommended for use in pregnant women or in patients with a known hypersensitivity to sulfonamides or thioamides.

See Also

• Tuberculosis
• Combination drug
• Sulfonamide
• Thioamide

Methaniazide/thioacetazone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia